FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely ophthalmology, and may be used in treating visual nerve and retinal diseases as neuroprotective therapy. That is ensured by introducing Corthexin 3 drops in both nasal passages every 2 minutes with the patient being in prone position. That is followed by a session of transcranial magnetic therapy in a projection of an optic tract with the use of the AMO-ATOS apparatus with the headband adaptor covering the temporal and occipital region. The procedure is daily for 10 days.
EFFECT: method is easy to implement, provides effective therapy, particularly of glaucomatous optic neuropathy in primary open-angle glaucoma that is ensured by the integrated effect on posterior eye segment, optic tracts including neurons of external geniculate bodies, as well as visual cortical representation.
11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PEOPLE WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2010 |
|
RU2425660C1 |
| METHOD OF DIAGNOSING ISCHEMIC NEUROOPTICOPATHY | 2010 |
|
RU2420235C1 |
| METHOD FOR POSTOPERATIVE REHABILITATION OF PATIENTS SUFFERING GLAUCOMA | 2013 |
|
RU2510254C1 |
| METHOD FOR PREDICTION THE RISK OF DEVELOPMENT OF PSEUDOEXFOLIATION GLAUCOMA | 2019 |
|
RU2710885C1 |
| METHOD OF COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2010 |
|
RU2472475C2 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD OF TREATING PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2012 |
|
RU2506062C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY IN INFANTS | 2011 |
|
RU2458702C1 |
| METHOD OF ESTIMATING STAGE OF INITIAL OPEN ANGLE GLAUCOMA PROGRESSING | 2011 |
|
RU2471405C1 |
| METHOD OF PREVENTING THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796891C1 |
